How Biotech and Pharmaceutical Companies Can Keep up with Complexity
The following is a guest post by Thomas Bentz, who is part of the Brand Marketing team at Dassault Systèmes. To view the exclusive webinar “Proactive Business Strategies that Improve Market Responsiveness and Long-term Sustainability,” click here.
Does your organization have the capacity for global expansion? As biotech and pharmaceutical companies pursue opportunity in maturing markets and emerging economies, they rely on commercial solutions to globally expand what has become an evolving vendor ecosystem. But opportunity has its price. Increasing the use of external resources to achieve clinical advancements and healthcare discoveries requires the best practices for managing the complexities of R&D and therapeutic innovation. Enterprises within the life sciences industries looking to squeeze the most out of their investments as they expand into new markets face the ultimate challenge: improve operational excellence to better deliver new therapies while minimizing and regulatory risk and cost.
Where do they begin?
Integrating from Within
How dynamic is your organization’s infrastructure? Managing complex processes and continuous data flow throughout a global supply chain is a daunting task in any industry. But for biotech and pharmaceutical organizations, maintaining agility and flexibility of portfolio management is especially imperative for achieving strategic growth and implementing organizational change. In the life sciences industry, these companies rely heavily on sharing extensive documentation, labeling and data with external partners in a fully controlled and regulatory manner to effectively deliver innovation. To maintain control, it is essential for organizations to operate with transparency and collaboration so that they can execute strategic decisions needed for market expansion and innovative development.
By having a holistic view into the portfolio, your enterprise has the ability to:
- Analyze the impact of systematic process changes greater control and compliance
- Create valuable, tactical insights used to achieve operational excellence
- Employ robust business practices need to foster innovative growth
- Deliver high-performing therapies with targeted focus on and patient promise.
Driving Organizational Change across Enterprise
Biotech and pharmaceutical innovators must rethink how they address these emerging global complexities and embrace organizational initiatives. In effort to achieve higher returns and greater value in product delivery while expanding performance capabilities, these organizations need more sophisticated solutions for information management than ever before.
It is becoming increasingly important that organizations address these challenges systemically while incorporating process improvements in ways that anticipate and more automatically address changes in the future. Life sciences organizations that proactively look for opportunities to implement change, can be the difference between a competing enterprise winning or losing in the global marketplace.
Biotech and pharmaceutical companies that also implement holistic solutions to successfully integrate quality, regulatory and compliance management systems across a single digital platform have the ability to:
- Adapt and manage complex processes and continuous data flow to meet evolving industry challenges and accelerate the innovation process
- Attain actionable insights for business strategies from end-to-end visibility of the portfolio
- Execute agile management strategies to achieve operational excellence and minimize risk while expanding into new markets
What else can biotech and pharmaceutical companies do to adapt to industry change?
In this exclusive webinar – “Proactive Business Strategies that Improve Market Responsiveness and Long-term Sustainability” – IDC Health Insights and Dassault Systèmes offer some additional ideas! You’ll learn the latest strategies pharmaceutical companies are using to tackle today’s challenge of expanding into new markets, while at the same time, reducing costs in the delivery of new advanced therapies. Click here to view the webinar and to learn more.